Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transition to Insulin Glargine U-300 in Children and Adolescents With Type 1 Diabetes
NCT07872475Phase 4Completed
- Sponsor
- Marmara University
- Start
- May 2025
- Primary completion
- Nov 2025
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glargine U300 in type 1 diabetes mellitus (T1D), sponsored by Marmara University. Started May 2025; status: completed.
02
Drugs
insulin glargine U300
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT07872475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07872475.